0.15 | 0.39%
| Price and Volume | |
|---|---|
| Recent Price | 38.85 |
| 52 Week High | 40.29 |
| 52 Week Low | 23.58 |
| Avg. Daily Vol. (Mil) | 0.21 |
| Beta (3 year) | 0.74 |
| Share Related Items | |
| Mkt Cap (Mil) | 1,069.90 |
| Shares Out (Mil) | 27.54 |
| Float (Mil) | 20.41 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 5.60 |
| Current Ratio | 7.20 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | 33.50 |
| Price/Sales | 5.05 |
| Price/Book | 6.18 |
| Price/Cash Flow | 29.00 |
| Per Share Data | |
| Earnings | 1.16 |
| Sales | 7.70 |
| Book Value | 6.29 |
| Cash Flow | 1.34 |
| Business Summary | |
|---|---|
| Cyberonics, Inc. is a neuromodulation company designs, develops, sells and markets implantable medical devices that provide a unique therapy, vagus nerve stimulation therapy for the treatment of refractory epilepsy and treatment-resistant depression. | |
| General Information | |
| 100 Cyberonics Boulevard
Houston, TX 77058 |
|
| www.cyberonics.com | |
| Industry : Health Services | |
| Sector: Health Care | |
| Employees: 484 | |
| CEO: Mr. Daniel Jeffrey Moore | |
| Short Interest | |
| Current Month (Mil) | 2.44 |
| Previous Month (Mil) | 2.38 |
| Short Interest Ratio (Days) | 13.00 |
| Management Effectiveness | |
| Return on Equity | 19.00 |
| Return on Assets | 16.60 |
| Return on Investments | 19.00 |
| Profitability | |
| Gross Margin | 91.80 |
| EBIT Margin | 26.30 |
| Profit Margin | 15.50 |
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,524.42 | 1,326.11 | 2,855.25 | 17.16 |
Oil *
106.83
|
|
UP
69.59 |
UP
8.29 |
UP
17.72 |
DOWN
0.29 |
10 Yr
1.72%
SPDR Gold
150.76
|
|
+0.56%
|
+0.63%
|
+0.62%
|
-1.66%
|
Data delayed 20 minutes |
Connect with TheStreet